News Archive

2015

July

Media Release / Jul 21, 2015

Novartis delivered solid performance in the second quarter, with strong innovation and progress on new launches

Read More
Media Release / Jul 16, 2015

Novartis malaria treatment Coartem® 80/480mg receives WHO prequalification, enabling greater access for patients

Read More

June

Media Release / Jun 30, 2015

Novartis Pharmaceuticals launches the first app for visually impaired people for use with the Apple Watch and other smart watches

Read More
Media Release / Jun 29, 2015

Novartis deepens its industry leading pipeline with acquisition of Spinifex Pharmaceuticals, Inc.

Read More
Media Release / Jun 29, 2015

Novartis announces publication in The Lancet showing sustained efficacy with secukinumab over one year in psoriatic arthritis patients

Read More
Media Release / Jun 26, 2015

Novartis drug Farydak® recommended by CHMP for EU approval to treat multiple myeloma, providing patients a new mechanism of action

Read More
Media Release / Jun 18, 2015

Sandoz announces US launch of Glatopa(TM), the first generic competitor to Copaxone® 20mg

Read More
Media Release / Jun 18, 2015

Novartis highlights strong innovation momentum at its second Meet Novartis Management investor day

Read More
Media Release / Jun 16, 2015

Alcon receives European approval for new trifocal presbyopia-correcting intraocular lens for patients undergoing cataract surgery

Read More
Media Release / Jun 13, 2015

Novartis presents new data from large European study reinforcing the benefit of first-line Tasigna® in newly-diagnosed patients with CML

Read More

Pages